48 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... with Community-Acquired ... Pneumonia (CAP) ... • Combination therapy ... fluoroquinolone #IDSA
CAP, HCAP, HAP and VAP - Diagnosis and Treatment

HCAP & CAP – those presenting to the
and Treatment ... twitter.com/foamid #CAP ... #Pneumonia #Acquired ... Diagnosis #Management #Treatment ... #InfectiousDisease
Table 4. Recommended Initial Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (Non-Ventilator-Associated Pneumonia) #Management #InfectiousDiseases #Empiric #Antibiotics
Empiric Antibiotic Therapy ... for Hospital-Acquired ... ) #Management #InfectiousDiseases ... #Antibiotics #HAP ... #HCAP #HospitalAcquiredPneumonia
Community Acquired Pneumonia - Inpatient and Outpatient Treatment Regimens
 • Outpatient, no significant comorbidities
 • Outpatient,
Community Acquired ... and Outpatient Treatment ... EricsMedicalLectures/ #CAP ... #Community #Acquired ... #management #pulmonary
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Infections • Pulmonary ... count <50 • Pulmonary ... of starting OI treatment ... Antiretroviral #Therapy ... Infections #management #infectiousdiseases
IDSA Recommended therapy for patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens #Duration #IDSA
IDSA Recommended ... therapy for patients ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... Regimens #Duration #IDSA
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... for effective treatment ... candida #mucosal #IDSA ... #Prevention #Treatment
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... escalation in therapy ... optimal inhaled therapy ... maximal inhaled therapy
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #pharmacology #IDSA ... #Guidelines #Treatment
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Quick Reference - Treatment ... follow up cultures required ... 14 days of IV therapy ... #Bacteremia #Treatment ... Management #Duration #infectiousdiseases